Our products form the cornerstone of integrated primary screening systems for the early detection of cancers. They are designed for implementation in diverse communities requiring minimum investment in supporting health infrastructure.
TruScreen
Early detection remains the key to minimising the risk of developing cervical cancer, but improvements in test accuracy are crucial. TruScreenŽ is a new approach that can help save lives. TruScreen® provides immediate results and remarkable accuracy.
SolarScan
Australia and New Zealand have the highest incidence of melanoma in the world. Reducing mortality from melanoma is highly dependent upon early diagnosis..
SolarScanŽ captures and analyses calibrated images of pigmented skin lesions that are stored for subsequent lesion monitoring or confirmation. Approved by the Melanoma Foundation.
Mediscan
MediScan® represents the frontline of the electronic health record - a truly integrated digital imaging and clinical management solution with a highly flexible data set at the point of care. Based on our extensive background and interaction with clinicians for clinical image and data collection in leading hospitals throughout the world Mediscan has been designed as a powerful electronic patient record that will interface easily within the wider hospital IT environment.
CerviScreen
Worldwide research has shown that the Human Papilloma Virus (HPV) is almost always the cause of cervical cancer. Polartechnics has developed a product called CerviScreen for the detection of the Human Papilloma Virus (HPV) in women. CerviScreen combines a patented DNA test together with a unique self sampling device for use by women in their own home.
